Pro-inflammatory cytokines and soluble receptors in response to acute psychosocial stress: Differential reactivity in bipolar disorder

Neuroscience Letters

Volumn 580, Issue , 2014, Pages 17-21

  Wieck, Andrea ^a   Grassi Oliveira, Rodrigo ^a   do Prado, Carine Hartmann ^a   Rizzo, Lucas Bortolotto ^a   de Oliveira, Agatha Schommer ^a   Kommers Molina, Júlia ^a   Viola, Thiago Wendt ^a   Marciano Vieira, Érica Leandro ^b   Teixeira, AntÔnio Lúcio ^b   Bauer, Moisés Evandro ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Bipolar disorder; Cytokines; Inflammation; Psychosocial stress

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 33; INTERLEUKIN 6; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; CELL SURFACE RECEPTOR; IL1RL1 PROTEIN, HUMAN;

ADULT; ARTICLE; BIPOLAR I DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; EXERCISE TEST; FEMALE; HUMAN; MENTAL STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRIER SOCIAL STRESS TEST; BIPOLAR DISORDER; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PSYCHOLOGY;

ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; MIDDLE AGED; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; STRESS, PSYCHOLOGICAL;

EID: 84905901890     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.07.040     Document Type: Article

References (38)

1. Aderka D., Engelmann H., Maor Y., Brakebusch C., Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp Med 1992, 175:323-329.
2. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 2003, 3:745-756.
3. Barbosa I.G., Huguet R.B., Mendonca V.A., Sousa L.P., Neves F.S., Bauer M.E., Teixeira A.L. Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder. Eur. Arch. Psychiatry Clin. Neurosci 2011, 261:139-143.
4. Barbosa I.G., Morato I.B., de Miranda A.S., Bauer M.E., Soares J.C., Teixeira A.L. A preliminary report of increased plasma levels of IL-33 in bipolar disorder: further evidence of pro-inflammatory status. J. Affect. Disord. 2014, 157:41-44.
5. Barbosa I.G., Rocha N.P., Huguet R.B., Ferreira R.A., Salgado J.V., Carvalho L.A., Pariante C.M., Teixeira A.L. Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers. J. Affect. Disord. 2012, 137:151-155.
6. Bierhaus A., Wolf J., Andrassy M., Rohleder N., Humpert P.M., Petrov D., Ferstl R., von Eynatten M., Wendt T., Rudofsky G., Joswig M., Morcos M., Schwaninger M., McEwen B., Kirschbaum C., Nawroth P.P. A mechanism converting psychosocial stress into mononuclear cell activation. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:1920-1925.
7. Buske-Kirschbaum A., Kern S., Ebrecht M., Hellhammer D.H. Altered distribution of leukocyte subsets and cytokine production in response to acute psychosocial stress in patients with psoriasis vulgaris. Brain Behav. Immun. 2007, 21:92-99.
8. Chen G., Manji H.K. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Curr. Opin. Psychiatry 2006, 19:313-323.
9. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., Manji H.K., Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J. Neurosci. 2003, 23:7311-7316.
10. Goldstein B.I., Kemp D.E., Soczynska J.K., McIntyre R.S. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J. Clin. Psychiatry 2009, 70:1078-1090.
11. Gosselin D., Rivest S. Role of IL-1 and TNF in the brain: twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system. Brain Behav. Immun. 2007, 21:281-289.
12. Grassi-Oliveira R., Brietzke E., Pezzi J.C., Lopes R.P., Teixeira A.L., Bauer M.E. Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder. Psychiatry Clin. Neurosci. 2009, 63:202-208.
13. Han P., Mi W.L., Wang Y.Q. Research progress on interleukin-33 and its roles in the central nervous system. Neurosci. Bull. 2011, 27:351-357.
14. Hoyer K.K., Dooms H., Barron L., Abbas A.K. Interleukin-2 in the development and control of inflammatory disease. Immunol. Rev. 2008, 226:19-28.
15. Izawa S., Sugaya N., Kimura K., Ogawa N., Yamada K.C., Shirotsuki K., Mikami I., Hirata K., Nagano Y., Nomura S. An increase in salivary interleukin-6 level following acute psychosocial stress and its biological correlates in healthy young adults. Biol. Psychol. 2013, 94:249-254.
16. Kapczinski F., Vieta E., Andreazza A.C., Frey B.N., Gomes F.A., Tramontina J., Kauer-Sant'anna M., Grassi-Oliveira R., Post R.M. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci. Biobehav. Rev. 2008, 32:675-692.
17. Kempuraj D., Khan M.M., Thangavel R., Xiong Z., Yang E., Zaheer A. Glia maturation factor induces interleukin-33 release from astrocytes: implications for neurodegenerative diseases. J. Neuroimmune Pharmacol. 2013, 8:643-650.
18. Kim Y.K., Jung H.G., Myint A.M., Kim H., Park S.H. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J. Affect. Disord. 2007, 104:91-95.
19. Kirschbaum C., Pirke K.M., Hellhammer D.H. The 'Trier Social Stress Test'-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993, 28:76-81.
20. Knijff E.M., Breunis M.N., Kupka R.W., de Wit H.J., Ruwhof C., Akkerhuis G.W., Nolen W.A., Drexhage H.A. An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment. Bipolar Disord. 2007, 9:743-753.
21. Kupfer D.J. The increasing medical burden in bipolar disorder. JAMA 2005, 293:2528-2530.
22. Lan R.Y., Selmi C., Gershwin M.E. The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2). J. Autoimmun. 2008, 31:7-12.
23. Malek T.R., Bayer A.L. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 2004, 4:665-674.
24. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
25. Milovanovic M., Volarevic V., Radosavljevic G., Jovanovic I., Pejnovic N., Arsenijevic N., Lukic M.L. IL-33/ST2 axis in inflammation and immunopathology. Immunol. Res. 2012, 52:89-99.
26. Modabbernia A., Taslimi S., Brietzke E., Ashrafi M. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol. Psychiatry 2013, 74:15-25.
27. Naranjo-Gomez M., Oliva H., Climent N., Fernandez M.A., Ruiz-Riol M., Bofill M., Gatell J.M., Gallart T., Pujol-Borrell R., Borras F.E. Expression and function of the IL-2 receptor in activated human plasmacytoid dendritic cells. Eur. J. Immunol. 2007, 37:1764-1772.
28. Ortiz-Dominguez A., Hernandez M.E., Berlanga C., Gutierrez-Mora D., Moreno J., Heinze G., Pavon L. Immune variations in bipolar disorder: phasic differences. Bipolar Disord. 2007, 9:596-602.
29. Pace T.W., Mletzko T.C., Alagbe O., Musselman D.L., Nemeroff C.B., Miller A.H., Heim C.M. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am. J. Psychiatry 2006, 163:1630-1633.
30. Post R.M., Leverich G.S. The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic intervention. Dev. Psychopathol. 2006, 18:1181-1211.
31. Raison C.L., Miller A.H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry 2003, 160:1554-1565.
32. Ritz T., Ayala E.S., Trueba A.F., Vance C.D., Auchus R.J. Acute stress-induced increases in exhaled nitric oxide in asthma and their association with endogenous cortisol. Am. J. Respir. Crit. Care Med. 2011, 183:26-30.
33. Sweet M.J., Leung B.P., Kang D., Sogaard M., Schulz K., Trajkovic V., Campbell C.C., Xu D., Liew F.Y. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J. Immunol. 2001, 166:6633-6639.
34. Trajkovic V., Sweet M.J., Xu D. T1/ST2-an IL-1 receptor-like modulator of immune responses. Cytokine Growth Factor Rev. 2004, 15:87-95.
35. Tsai S.Y., Chung K.H., Wu J.Y., Kuo C.J., Lee H.C., Huang S.H. Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder. J. Affect. Disord. 2012, 136:110-116.
36. von Kanel R., Kudielka B.M., Preckel D., Hanebuth D., Fischer J.E. Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men. Brain Behav. Immun. 2006, 20:40-48.
37. Wieck A., Grassi-Oliveira R., do Prado C.H., Rizzo L.B., de Oliveira A.S., Kommers-Molina J., Viola T.W., Teixeira A.L., Bauer M.E. Differential neuroendocrine and immune responses to acute psychosocial stress in women with type 1 bipolar disorder. Brain Behav. Immun. 2013, 34:47-55.
38. Xanthoulea S., Pasparakis M., Kousteni S., Brakebusch C., Wallach D., Bauer J., Lassmann H., Kollias G. Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases. J. Exp. Med. 2004, 200:367-376.